Nalaganje...
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds
Transglutaminase 2 (EC 2.3.2.13; TG2 or TGase 2) plays important roles in the pathogenesis of many diseases, including cancers, neurodegeneration, and inflammatory disorders. Under normal conditions, however, mice lacking TGase 2 exhibit no obvious abnormal phenotype. TGase 2 expression is induced b...
Shranjeno v:
| izdano v: | Med Sci (Basel) |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313797/ https://ncbi.nlm.nih.gov/pubmed/30297644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci6040087 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|